Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma

Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The efficacy of immunotherapy usually depends on the interaction of immunomodulation in the tumor microenvironment (TME). This study aimed to explore the potential stromal-immune score-based prognosti...

Full description

Bibliographic Details
Main Authors: Shixin Xiang, Jing Li, Jing Shen, Yueshui Zhao, Xu Wu, Mingxing Li, Xiao Yang, Parham Jabbarzadeh Kaboli, Fukuan Du, Yuan Zheng, Qinglian Wen, Chi Hin Cho, Tao Yi, Zhangang Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.653836/full
id doaj-dd696fee1d2d4bc0922dba1fcc05097b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Shixin Xiang
Shixin Xiang
Jing Li
Jing Shen
Jing Shen
Yueshui Zhao
Yueshui Zhao
Xu Wu
Xu Wu
Mingxing Li
Mingxing Li
Xiao Yang
Parham Jabbarzadeh Kaboli
Parham Jabbarzadeh Kaboli
Fukuan Du
Fukuan Du
Yuan Zheng
Qinglian Wen
Chi Hin Cho
Chi Hin Cho
Chi Hin Cho
Tao Yi
Zhangang Xiao
Zhangang Xiao
spellingShingle Shixin Xiang
Shixin Xiang
Jing Li
Jing Shen
Jing Shen
Yueshui Zhao
Yueshui Zhao
Xu Wu
Xu Wu
Mingxing Li
Mingxing Li
Xiao Yang
Parham Jabbarzadeh Kaboli
Parham Jabbarzadeh Kaboli
Fukuan Du
Fukuan Du
Yuan Zheng
Qinglian Wen
Chi Hin Cho
Chi Hin Cho
Chi Hin Cho
Tao Yi
Zhangang Xiao
Zhangang Xiao
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
Frontiers in Immunology
tumor microenvironment
Hepatocellular carcinoma
TCGA
ESTIMATE algorithm
Prognosis
author_facet Shixin Xiang
Shixin Xiang
Jing Li
Jing Shen
Jing Shen
Yueshui Zhao
Yueshui Zhao
Xu Wu
Xu Wu
Mingxing Li
Mingxing Li
Xiao Yang
Parham Jabbarzadeh Kaboli
Parham Jabbarzadeh Kaboli
Fukuan Du
Fukuan Du
Yuan Zheng
Qinglian Wen
Chi Hin Cho
Chi Hin Cho
Chi Hin Cho
Tao Yi
Zhangang Xiao
Zhangang Xiao
author_sort Shixin Xiang
title Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
title_short Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
title_full Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
title_fullStr Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
title_full_unstemmed Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
title_sort identification of prognostic genes in the tumor microenvironment of hepatocellular carcinoma
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-04-01
description Background: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The efficacy of immunotherapy usually depends on the interaction of immunomodulation in the tumor microenvironment (TME). This study aimed to explore the potential stromal-immune score-based prognostic genes related to immunotherapy in HCC through bioinformatics analysis.Methods: ESTIMATE algorithm was applied to calculate the immune/stromal/Estimate scores and tumor purity of HCC using the Cancer Genome Atlas (TCGA) transcriptome data. Functional enrichment analysis of differentially expressed genes (DEGs) was analyzed by the Database for Annotation, Visualization, and Integrated Discovery database (DAVID). Univariate and multivariate Cox regression analysis and least absolute shrinkage and selection operator (LASSO) regression analysis were performed for prognostic gene screening. The expression and prognostic value of these genes were further verified by KM-plotter database and the Human Protein Atlas (HPA) database. The correlation of the selected genes and the immune cell infiltration were analyzed by single sample gene set enrichment analysis (ssGSEA) algorithm and Tumor Immune Estimation Resource (TIMER).Results: Data analysis revealed that higher immune/stromal/Estimate scores were significantly associated with better survival benefits in HCC within 7 years, while the tumor purity showed a reverse trend. DEGs based on both immune and stromal scores primarily affected the cytokine–cytokine receptor interaction signaling pathway. Among the DEGs, three genes (CASKIN1, EMR3, and GBP5) were found most significantly associated with survival. Moreover, the expression levels of CASKIN1, EMR3, and GBP5 genes were significantly correlated with immune/stromal/Estimate scores or tumor purity and multiple immune cell infiltration. Among them, GBP5 genes were highly related to immune infiltration.Conclusion: This study identified three key genes which were related to the TME and had prognostic significance in HCC, which may be promising markers for predicting immunotherapy outcomes.
topic tumor microenvironment
Hepatocellular carcinoma
TCGA
ESTIMATE algorithm
Prognosis
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.653836/full
work_keys_str_mv AT shixinxiang identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT shixinxiang identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT jingli identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT jingshen identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT jingshen identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT yueshuizhao identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT yueshuizhao identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT xuwu identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT xuwu identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT mingxingli identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT mingxingli identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT xiaoyang identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT parhamjabbarzadehkaboli identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT parhamjabbarzadehkaboli identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT fukuandu identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT fukuandu identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT yuanzheng identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT qinglianwen identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT chihincho identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT chihincho identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT chihincho identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT taoyi identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT zhangangxiao identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
AT zhangangxiao identificationofprognosticgenesinthetumormicroenvironmentofhepatocellularcarcinoma
_version_ 1721536014264041472
spelling doaj-dd696fee1d2d4bc0922dba1fcc05097b2021-04-07T13:22:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-04-011210.3389/fimmu.2021.653836653836Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular CarcinomaShixin Xiang0Shixin Xiang1Jing Li2Jing Shen3Jing Shen4Yueshui Zhao5Yueshui Zhao6Xu Wu7Xu Wu8Mingxing Li9Mingxing Li10Xiao Yang11Parham Jabbarzadeh Kaboli12Parham Jabbarzadeh Kaboli13Fukuan Du14Fukuan Du15Yuan Zheng16Qinglian Wen17Chi Hin Cho18Chi Hin Cho19Chi Hin Cho20Tao Yi21Zhangang Xiao22Zhangang Xiao23Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaDepartment of Oncology and Hematology, Hospital (T.C.M) Affiliated to Southwest Medical University, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaNeijiang Health and Health Vocational College, Neijiang, ChinaDepartment of Oncology, Affiliated Hospital of Southwest Medical University, Luzhou, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaSouth Sichuan Institute of Translational Medicine, Luzhou, ChinaFaculty of Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, ChinaSchool of Chinese Medicine, Hong Kong Baptist University, Hong Kong, ChinaLaboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, ChinaDepartment of Pharmacy, The Affiliated Hospital of Southwest Medical University, Luzhou, ChinaBackground: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. The efficacy of immunotherapy usually depends on the interaction of immunomodulation in the tumor microenvironment (TME). This study aimed to explore the potential stromal-immune score-based prognostic genes related to immunotherapy in HCC through bioinformatics analysis.Methods: ESTIMATE algorithm was applied to calculate the immune/stromal/Estimate scores and tumor purity of HCC using the Cancer Genome Atlas (TCGA) transcriptome data. Functional enrichment analysis of differentially expressed genes (DEGs) was analyzed by the Database for Annotation, Visualization, and Integrated Discovery database (DAVID). Univariate and multivariate Cox regression analysis and least absolute shrinkage and selection operator (LASSO) regression analysis were performed for prognostic gene screening. The expression and prognostic value of these genes were further verified by KM-plotter database and the Human Protein Atlas (HPA) database. The correlation of the selected genes and the immune cell infiltration were analyzed by single sample gene set enrichment analysis (ssGSEA) algorithm and Tumor Immune Estimation Resource (TIMER).Results: Data analysis revealed that higher immune/stromal/Estimate scores were significantly associated with better survival benefits in HCC within 7 years, while the tumor purity showed a reverse trend. DEGs based on both immune and stromal scores primarily affected the cytokine–cytokine receptor interaction signaling pathway. Among the DEGs, three genes (CASKIN1, EMR3, and GBP5) were found most significantly associated with survival. Moreover, the expression levels of CASKIN1, EMR3, and GBP5 genes were significantly correlated with immune/stromal/Estimate scores or tumor purity and multiple immune cell infiltration. Among them, GBP5 genes were highly related to immune infiltration.Conclusion: This study identified three key genes which were related to the TME and had prognostic significance in HCC, which may be promising markers for predicting immunotherapy outcomes.https://www.frontiersin.org/articles/10.3389/fimmu.2021.653836/fulltumor microenvironmentHepatocellular carcinomaTCGAESTIMATE algorithmPrognosis